INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 435m ago
House PTR34m ago
SEC 13F34m ago
Robinhood Chain34m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

18,675 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
SC
Sumner CrystalSee Remarks
MQMarqeta, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
5,056 sh
Jun 15, 2026Jun 16, 2026
Page 202 of 467
← PrevNext →
traded Jun 15, 2026
+1d
SEC Form 4

Evidence

16
AA
Aragone AugustoExecutive VP, Secretary & GC
INGMIngram Micro Holding Corp
Open-market sale · 10b5-1 plan
SELL$300K
10.0K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

15
AF
Ahearn Matthew FraserDirector, Chief Operating Officer
SISHOULDER INNOVATIONS, INC.
Open-market sale · 10b5-1 plan
SELL$296K
15.9K sh
Jun 12, 2026Jun 16, 2026
traded Jun 12, 2026
+4dSEC Form 4

Evidence

15
MP
McQuarrie David P.Chief Commercial Officer
HPQHP INC
Open-market sale · 10b5-1 plan
SELL$260K
10.5K sh
Jun 12, 2026Jun 16, 2026
traded Jun 12, 2026
+4dSEC Form 4

Evidence

14
RY
Rozenberg Haine YaelVP Finance
VLNValens Semiconductor Ltd.
Open-market sale · 10b5-1 plan
SELL$41K
17.4K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

13
VH
von Heynitz HaraldDirector
FLNCFluence Energy, Inc.
Open-market sale · 10b5-1 plan
SELL$125K
5,000 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

12
EM
Ellenbogen MichaelDirector
EVLVEvolv Technologies Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$501K
80.7K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

11
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
116 sh
Jun 16, 2026Jun 16, 2026
traded Jun 16, 2026
+0dSEC Form 4

Evidence

10
RY
Rozenberg Haine YaelVP Finance
VLNValens Semiconductor Ltd.
Open-market sale · 10b5-1 plan
SELL$3,429
1,453 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

4
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$135K
2,104 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

4
PJ
Prahm JeremyChief Investment Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$181K
8,860 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

4
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Open-market sale · 10b5-1 plan
SELL$881K
57.9K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

4
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
1,596 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

3
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Open-market sale · 10b5-1 plan
SELL$9,730
4,000 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
200 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
AF
Ahearn Matthew FraserDirector, Chief Operating Officer
SISHOULDER INNOVATIONS, INC.
Open-market sale · 10b5-1 plan
SELL$48K
2,500 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$6,563
100 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
FJ
Fiedler-Kelly JillPresident, Services Solutions
SLPSimulations Plus, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
1,050 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
AF
Ahearn Matthew FraserDirector, Chief Operating Officer
SISHOULDER INNOVATIONS, INC.
Open-market sale · 10b5-1 plan
SELL$30K
1,644 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
AE
Alvarez Divo Carlos EduardoDirector
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
10.7K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

51
RA
Rosenberg AaronChief Financial Officer
ONCBeOne Medicines Ltd.
Open-market sale
SELL$163K
631 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

50
HJ
Haas JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$886K
3,461 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

50
HJ
Haas JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$765K
3,000 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

47
WL
Wang LaiPresident, Global Head of R&D
ONCBeOne Medicines Ltd.
Open-market sale
SELL$197K
756 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

44
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale
SELL$110K
428 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

43
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$2.67M
23.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

40
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$878K
7,500 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

40
AL
Anderson Dyaarl Lee Jr.Chief Commercial Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$9,525
4,739 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

39
AG
Abbott Paul GDirector, Chief Executive Officer
GBTGGlobal Business Travel Group, Inc.
Open-market sale
SELL$5.37M
574.3K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

37
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$445K
3,418 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

37
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$2,460
130 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC Form 4

Evidence

37
HJ
Hill Stephen J.Chief Operating Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$1,684
89 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC Form 4

Evidence

37
BS
Bulis Veronica SanchezVP, Corporate Controller
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$4,103
217 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC Form 4

Evidence

36
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$524K
4,449 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

36
ID
Inglis Tiffany Eul DavisChief Medical Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$728
362 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

32
LZ
Lindgardt ZhenyaDirector, Chief Executive Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$14K
6,990 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

32
AA
Aerts AustinChief Financial Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$4,094
2,037 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

32
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$279K
2,348 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

31
FL
Feldmann Cynthia LDirector
UFPTUFP TECHNOLOGIES INC
Open-market sale
SELL$263K
1,100 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

31
SN
Schmitt Thomas NCPO, Skyward Group
SKWDSkyward Specialty Insurance Group, Inc.
Open-market sale
SELL$431K
8,397 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence